Epimacular brachytherapy for neovascular age-related macular degeneration: A randomized, controlled trial (CABERNET)

Ophthalmology

Volumn 120, Issue 2, 2013, Pages 317-327

  Dugel, Pravin U ^a   Bebchuk, Judith D ^b   Nau, Jeffrey ^c   Reichel, Elias ^d   Singer, Michael ^e   Barak, Adiel ^f   Binder, Susanne ^g   Jackson, Timothy L ^h  

^a RETINAL CONSULTANTS OF ARIZONA   (United States)

^b University of Iowa   (United States)

^c NeoVista Inc   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e Medical Center Ophthalmology Associates   (United States)

^f TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^g KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^h KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

ADULT; ARTICLE; BRACHYTHERAPY; CATARACT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; EPIMACULAR BRACHYTHERAPY; EXUDATIVE MACULAR DEGENERATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NEOVASCULAR RETINA MACULA AGE RELATED DEGENERATION; NONPROLIFERATIVE RADIATION RETINOPATHY; OUTCOME ASSESSMENT; PATIENT SAFETY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION INJURY; RADIATION SAFETY; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; RETINOPATHY; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; BRACHYTHERAPY; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MACULA LUTEA; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; STRONTIUM RADIOISOTOPES; TREATMENT OUTCOME; VISUAL ACUITY; WET MACULAR DEGENERATION; YTTRIUM RADIOISOTOPES;

EID: 84873316131     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2012.07.068     Document Type: Article

References (39)

1. R.P. Finger, R. Fimmers, F.G. Holz, H.P. Scholl Incidence of blindness and severe visual impairment in Germany: projections for 2030 Invest Ophthalmol Vis Sci 52 2011 4381 4389
2. N. Congdon, B. O'Colmain, C.C. Klaver Eye Diseases Prevalence Research Group Causes and prevalence of visual impairment among adults in the United States Arch Ophthalmol 122 2004 477 485
3. E. Gunnlaugsdottir, A. Arnarsson, F. Jonasson Five-year incidence of visual impairment and blindness in older Icelanders: the Reykjavik Eye Study Acta Ophthalmol 88 2010 358 366
4. C. Bunce, W. Xing, R. Wormald Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008 Eye (Lond) 24 2010 1692 1699
5. N.M. Bressler, Q.V. Doan, R. Varma Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-Hispanic white population in the United States with age-related macular degeneration Arch Ophthalmol 129 2011 709 717
6. D.J. D'Amico, H.N. Masonson, M. Patel VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials Ophthalmology 113 2006 992 1001
7. U. Chakravarthy, A.P. Adamis, E.T. Cunningham Jr VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration Ophthalmology 113 2006 1508 1521
8. D.M. Brown, P.K. Kaiser, M. Michels ANCHOR Study Group Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 2006 1432 1444
9. D.M. Brown, M. Michels, P.K. Kaiser ANCHOR Study Group Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: two-year results of the ANCHOR Study Ophthalmology 116 2009 57 65
10. P.J. Rosenfeld, D.M. Brown, J.S. Heier MARINA Study Group Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431
11. P. Abraham, H. Yue, L. Wilson Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 2 Am J Ophthalmol 150 2010 315 324
12. Regeneron Pharmaceuticals, Inc. Eylea [package insert]. Full prescribing information 2011 http://www.regeneron.com/Eylea/eylea-fpi.pdf Accessed June 7, 2012
13. M.W. Stewart, S. Grippon, P. Kirkpatrick Aflibercept [news] Nat Rev Drug Discov 11 2012 269 270
14. D.F. Martin, M.G. Maguire, G.S. Ying CATT Research Group Ranibizumab and bevacizumab for neovascular age-related macular degeneration N Engl J Med 364 2011 1897 1908
15. X.W. Mao A quantitative study of the effects of ionizing radiation on endothelial cells and capillary-like network formation Technol Cancer Res Treat 5 2006 127 134
16. A.M. Maguire, A.P. Schachat Radiation retinopathy S.J. Ryan, T.E. Ogden, D.R. Hinton, A.P. Schachat, C.P. Wilkinson, 3rd ed. Retina vol. 2 2001 Mosby St Louis, MO 1509 1510 ed-in-chief
17. R.L. De Gowin, L.J. Lewis, J.C. Hoak Radiosensitivity of human endothelial cells in culture J Lab Clin Med 84 1974 42 48
18. U. Chakravarthy, T.A. Gardiner, D.B. Archer, C.J. Maguire A light microscopic and autoradiographic study of non-irradiated and irradiated ocular wounds Curr Eye Res 8 1989 337 348
19. U. Chakravarthy, R.F. Houston, D.B. Archer Treatment of age-related subfoveal neovascular membranes by teletherapy: a pilot study Br J Ophthalmol 77 1993 265 273
20. U. Chakravarthy, G. MacKenzie External beam radiotherapy in exudative age-related macular degeneration: a pooled analysis of phase I data Br J Radiol 73 2000 305 313
21. G.J. Bergink, C.B. Hoyng, R.W. van der Maazen A randomized controlled clinical trial on the efficacy of radiation therapy in the control of subfoveal choroidal neovascularization in age-related macular degeneration: radiation versus observation Graefes Arch Clin Exp Ophthalmol 236 1998 321 325
22. C. Valmaggia, G. Ries, P. Ballinari Radiotherapy for subfoveal choroidal neovascularization in age-related macular degeneration: a randomized clinical trial Am J Ophthalmol 133 2002 521 529
23. Radiation Therapy for Age-related Macular Degeneration (RAD) Study Group A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study) Ophthalmology 106 1999 2239 2247
24. H. Paganetti, A. Niemierko, M. Ancukiewicz Relative biological effectiveness (RBE) values for proton beam therapy Int J Radiat Oncol Biol Phys 53 2002 407 421
25. W. Kilby, J.R. Dooley, G. Kuduvalli The CyberKnife Robotic Radiosurgery System in 2010 Technol Cancer Res Treat 9 2010 433 452
26. K.M. Prise, O.V. Belyakov, M. Folkard, B.D. Michael Studies of bystander effects in human fibroblasts using a charged particle microbeam Int J Radiat Biol 74 1998 793 798
27. D.M. Moshfeghi, P.K. Kaiser, M. Gertner Stereotactic low-voltage x-ray irradiation for age-related macular degeneration Br J Ophthalmol 95 2011 185 188
28. R. Petrarca, T.L. Jackson Radiation therapy for neovascular age-related macular degeneration Clin Ophthalmol 5 2011 57 63
29. R.F. Moore Choroidal sarcoma treated by the intraocular insertion of radon seeds Br J Ophthalmol 14 1930 145 152
30. R. van Ginderdeuren, E. van Limbergen, W. Spileers 18 years' experience with high dose rate strontium-90 brachytherapy of small to medium sized posterior uveal melanoma Br J Ophthalmol 89 2005 1306 1310
31. A. Jaakkola, J. Heikkonen, A. Tarkkanen, I. Immonen Visual function after strontium-90 plaque irradiation in patients with age-related subfoveal choroidal neovascularization Acta Ophthalmol Scand 77 1999 57 61
32. A. Jaakkola, J. Heikkonen, P. Tommila Strontium plaque brachytherapy for exudative age-related macular degeneration: three-year results of a randomized study Ophthalmology 112 2005 567 573
33. M.P. Avila, M.E. Farah, A. Santos Three-year safety and visual acuity results of epimacular 90 strontium/90 yttrium brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration Retina 32 2012 10 18
34. P.U. Dugel, R. Petrarca, M. Bennett Macular epiretinal brachytherapy in treated age-related macular degeneration: MERITAGE Study: twelve-month safety and efficacy results Ophthalmology 119 2012 1425 1431
35. Early Treatment Diabetic Retinopathy Study Research Group Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1 Arch Ophthalmol 103 1985 1796 1806
36. Antiplatelet Trialists' Collaboration Collaborative overview of randomised trials of antiplatelet therapy - I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ 308 1994 81 106
37. L. Wickham, C. Bunce, D. Wong Randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy Ophthalmology 114 2007 698 704
38. H. Heimann, K.U. Bartz-Schmidt, N. Bornfeld Scleral Buckling versus Primary Vitrectomy in Rhegmatogenous Retinal Detachment Study Group Scleral buckling versus primary vitrectomy in rhegmatogenous retinal detachment: a prospective randomized multicenter clinical study Ophthalmology 114 2007 2142 2154
39. R.C. Chan, L.J. Shukovsky Effects of irradiation on the eye Radiology 120 1976 673 675